Pancreatic Cancer Research

ResearcherJiangsu UniversityNo recent work listed

Lu Ge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5782-4823; OpenAlex author ID A5000545627. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 3

  1. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. Co-author DOI 10.1111/jcmm.14894↗
  2. Long non‑coding RNA PVT1 promotes epithelial‑mesenchymal transition via the TGF‑β/Smad pathway in pancreatic cancer cells. Co-author DOI 10.3892/or.2018.6462↗
  3. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.7507↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Youli Zhang · 3 shared papers, 2016–2020 · strength 0.24
  2. Aihua Gong · 3 shared papers, 2016–2020 · strength 0.24
  3. Wan‐Xin Peng · 3 shared papers, 2016–2020 · strength 0.24
  4. Min Xu · 3 shared papers, 2016–2020 · strength 0.24
  5. Huizhi Wang · 1 shared paper, 2020 · strength 0.11
  6. Xingxing Zhang · 1 shared paper, 2018 · strength 0.08
  7. Yin‐Yuan Mo · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.